MedTrace Logo

Fractional Resurfacing Device for Treatment of Acne Scarring

NCT00585286 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-01-15

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to evaluate the safety and effectiveness of a new investigational laser device for treatment of acne scarring, for improvement in the appearance of surface texture and topography (recessed or uneven surfaces).

Conditions

Interventions

DEVICE

10,600 nm fractional carbon dioxide laser system

1-3 laser treatments using 20-100 millijoules (mJ) with 100-400 microscopic treatment zones (MTZ)/cm2 per pass and total density of 600-1200 MTZ/cm2

Sponsors & Collaborators

  • Reliant Technologies, Inc. Mountain View, CA

    collaborator INDUSTRY

  • University of Minnesota

    collaborator OTHER

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Christopher B Zachary, MBBS, FRCP · University of California, Irvine

  • Brian D Zelickson, MD · Department of Dermatology, University of Minnesota, Minneapolis, Minnesota

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00585286 on ClinicalTrials.gov